New Developments in Restless Legs Syndrome
Medications which are under investigation for restless legs syndrome include:
- Amantadine
- Selegeline
- Valproate (Depakene)
- Lamotrigine (Lamictil)
- Baclofen (Lioresal)
NSAIDs (nonsteroidal anti-inflammatory drugs)
Drug delivery systems under investigation for restless legs syndrome, including:
- skin patches for controlled delivery
- intramuscular or subcutaneous (under the skin) slow release medication
- epidural infusion where measured doses of a drug can be delivered as needed via an implanted pump
Other aspects of restless legs syndrome under investigation include:
- creating and validating tests to measure quality of life changes
- comparative studies of various dopamine agonists and other medications
- long-term effectiveness of drugs on restless legs syndrome and PLMS
- treatment of children with restless legs syndrome
- treatment of women during pregnancy
- learning more about the causes and pathophysiology of restless legs syndrome
- developing new and more effective long-term treatments for restless legs syndrome
- determining why augmentation of restless legs syndrome symptoms occurs in some patients being treated with dopaminergic drugs and how to prevent this phenomenon.
- identifying the genes involves in restless legs syndrome
- elucidating the relationship between pregnancy and the development of restless legs syndrome in some patients
Previous Section
